elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate

CHEBI:CHEBI_754212

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

active_ingredient_name
COBICISTAT
rxcui
1306298
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
route
ORAL
listing_expiration_date
20241231
dosage_form
TABLET, FILM COATED
pharm_class_moa
HIV Integrase Inhibitors [MoA]
pharm_class
Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
active_ingredient_strength
300 mg/1
nui
N0000175887
unii
4GDQ854U53
pharm_class_epc
Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
pharm_class_cs
Nucleosides [CS]
labeler_name
Gilead Sciences, Inc.
manufacturer_name
Gilead Sciences, Inc.
marketing_start_date
20120827
package_marketing_start_date
20120827
generic_name
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate
brand_name
Stribild
brand_name_base
Stribild
product_ndc
61958-1201
application_number
NDA203100
spl_id
f2f65f0b-1902-4a49-bee3-f854b1863545
package_ndc
61958-1201-1
package_description
30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-1201-1)
spl_set_id
74ae2a93-b267-444c-8f0f-a2a6522260ee
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class